- A number of Covid-19 patients in the United Kingdom are going to receive aspirin as part of their treatment
- The trial will be used to see whether aspirin can reduce the risk of blood clots that come with the Coronavirus
- Patients who are going to be part of the trial will receive aspirin as part of their treatment along with the usual Covid-19 treatment daily
People who are infected with Covid-19 in the UK are going to be given aspirin as part of a medical trial. The drug has been added to a list of possible treatments as part of the Randomised Evaluation of Covid-19 therapy (Recovery) trial.
According to scientists, people who have been infected with Covid-19 are at a higher risk of suffering from deadly blood clots.
Experts are hopeful that aspirin, which is commonly used as a blood thinner can help with the reduction of dangerous blood clots. Small doses of the medication can also be used to lessen the risk of some cancers.
Co-chief investigator of the trial, Professor Martin Landray says that aspirin is commonly used to treat a number of conditions.
"Enrolling patients in a randomised trial such as Recovery is the only way to assess whether there are clear benefits for patients with Covid-19,” he said.
About 2 000 patients are set to receive 150mg of aspirin as their treatment every day. This will be along with their usual medication. This data will be compared to the patients who receive regular Covid-19 treatment on its own.
In other news, Briefly.co.za reported that Covid-19 positive matrics may now write exams. The 2020 Matric Exams have kicked off in South Africa on Thursday and the Department of Basic Education has already pulled a u-turn.
After previously warning against testing positive, the Department says that it has reached an 'agreement' in order to allow infected students to write their year-end exams:
"The Department of Basic Education and the Department of Health have just concluded an agreement this evening that will ensure that learners who test positive for Covid-19 are allowed to write the final matric examinations."
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!